Provectus Biopharmaceuticals, Inc.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Jan 2002 | — | $0 | — |
| Jan 2002 | — | $0 | — |
| Apr 2002 | — | $802 | — |
| Dec 2002 | — | $11.7M | — |
| Dec 2003 | — | $10.3M | — |
| Dec 2004 | — | $9.2M | — |
| Dec 2005 | — | $14.4M | — |
| Dec 2006 | — | $15.5M | — |
| Dec 2007 | — | $14.8M | — |
| Dec 2008 | — | $10.1M | $2.8M |
| Dec 2009 | — | $9.4M | $3.2M |
| Jun 2010 | — | — | $12.5M |
| Sep 2010 | — | — | $10.0M |
| Dec 2010 | — | $10.7M | $8.1M |
| Mar 2011 | — | — | $12.4M |
| Jun 2011 | — | $14.8M | $14.4M |
| Sep 2011 | — | $12.2M | $10.8M |
| Dec 2011 | — | $10.0M | $7.7M |
| Mar 2012 | — | $6.2M | $4.9M |
| Jun 2012 | — | $4.9M | $4.1M |
| Sep 2012 | — | $3.4M | $1.8M |
| Dec 2012 | — | $4.4M | $1.2M |
| Mar 2013 | — | $5.5M | $4.3M |
| Jun 2013 | — | $6.3M | $4.6M |
| Sep 2013 | — | $8.7M | $8.3M |
| Dec 2013 | — | $6.6M | $15.7M |
| Mar 2014 | — | $14.5M | $16.6M |
| Jun 2014 | — | $20.0M | $18.1M |
| Sep 2014 | — | $19.5M | $17.8M |
| Dec 2014 | — | $25.2M | $17.4M |
| Mar 2015 | — | $21.7M | $14.2M |
| Jun 2015 | — | $30.2M | $23.1M |
| Sep 2015 | — | $24.5M | $18.9M |
| Dec 2015 | — | $16.3M | $14.2M |
| Mar 2016 | — | $14.2M | $9.8M |
| Jun 2016 | — | $9.1M | $4.9M |
| Sep 2016 | — | $5.3M | $5.2M |
| Dec 2016 | — | $3.5M | $1.2M |
| Mar 2017 | — | $-920.3K | $437.0K |
| Jun 2017 | — | $-4.2M | $1.1M |
| Sep 2017 | — | $-7.3M | $208.3K |
| Dec 2017 | — | $-10.0M | $105.5K |
| Mar 2018 | — | $-12.5M | $244.1K |
| Jun 2018 | — | $-13.7M | $130.6K |
| Sep 2018 | — | $-15.3M | $231.9K |
| Dec 2018 | — | $-17.4M | $51.0K |
| Mar 2019 | — | $-18.8M | $1.8M |
| Jun 2019 | — | $-21.0M | $1.3M |
| Sep 2019 | — | $-22.6M | $434.8K |
| Dec 2019 | — | $-24.1M | $590.7K |
| Mar 2020 | — | $-25.9M | $213.7K |
| Jun 2020 | — | $-27.5M | $1.5M |
| Sep 2020 | — | $-28.7M | $986.5K |
| Dec 2020 | — | $-30.2M | $97.2K |
| Mar 2021 | — | $-31.6M | $349.8K |
| Jun 2021 | — | $-2.6M | $47.4K |
| Sep 2021 | — | $-2.9M | $254.1K |
| Dec 2021 | — | $-4.2M | $683.0K |
| Mar 2022 | — | $-5.1M | $173.6K |
| Jun 2022 | — | $-6.1M | $84.3K |
| Sep 2022 | — | $-6.9M | $67.0K |
| Dec 2022 | — | $-6.2M | $21.6K |
| Mar 2023 | — | $-7.0M | $34.2K |
| Jun 2023 | — | $-7.3M | $176.0K |
| Sep 2023 | — | $-7.5M | $367.3K |
| Dec 2023 | — | $-7.6M | $76.6K |
| Mar 2024 | — | $-7.4M | $18.0K |
| Jun 2024 | — | $-7.5M | $29.6K |
| Sep 2024 | — | $-5.4M | $187.5K |
| Dec 2024 | — | $-6.0M | $307.4K |
| Mar 2025 | — | $-5.1M | $390.4K |
| Jun 2025 | — | $-5.9M | $385.9K |
| Sep 2025 | — | $-6.2M | $72.5K |
| Dec 2025 | — | $-6.3M | $251.3K |
| Mar 2026 | — | $-6.7M | $223.9K |
| Jun 2026 | — | $-6.3M | $1.2M |